Molded porous poly (L-lactide) membranes for guided bone regeneration with enhanced effects by controlled growth factor release.
The aim of this study was to develop platelet-derived growth factor (PDGF-BB) loaded moldable porous poly (L-lactide) (PLLA)-tricalcium phosphate (TCP) membranes for guided bone regeneration (GBR) therapy. The membranes were designed to fit various types of bone defect sites. PDGF-BB-dissolved PLLA-TCP in methylene chloride-ethyl acetate solution was cast on a dome shaped metallic mold to fabricate a model membrane. The release rate of PDGF-BB, the osteoblast attachment test, and guided bone regeneration potential were evaluated with PDGF-BB-loaded PLLA-TCP membranes. Regular pores were generated throughout the membrane mainly due to phase inversion of PLLA-methylene chloride-ethyl acetate solution. A therapeutic amount of PDGF-BB was released from the membrane. The release rate could be controlled by varying the initial loading content of PDGF-BB. A significant amount of cells attached onto the PDGF-BB-loaded membrane rather than onto the unloaded membrane. Dome shaped bone formation was achieved in rabbit calvaria at 4 weeks. This indicated that restoration of bone defects to the bone's original shape can be made possible by using molded membranes, which guide bone regeneration along with providing sufficient spaces. Bone forming efficiency was increased remarkably due to PDGF-BB release from PLLA-TCP membranes. These results suggested that the PDGF-BB releasing molded PLLA-TCP membrane may potentially improve GBR efficiency in various types of bone defects.
Lee
S J
SJ
Department of Industrial Pharmacy, College of Pharmacy, Ewha Woman's University, 11-1 Daehyun-Dong, Seodaemun-Ku, Seoul 120-750, Korea. sjlee@mm.ewha.ac.kr
Park
Y J
YJ
Park
S N
SN
Lee
Y M
YM
Seol
Y J
YJ
Ku
Y
Y
Chung
C P
CP
D000818:Animals; D000077214:Becaplermin; D001672:Biocompatible Materials; D001842:Bone and Bones / Q000502:physiology*; D002130:Calcium Phosphates; D002448:Cell Adhesion; D003692:Delayed-Action Preparations; D048091:Guided Tissue Regeneration / Q000379:methods*; D066298:In Vitro Techniques; D008297:Male; D008422:Materials Testing; D008567:Membranes, Artificial; D008855:Microscopy, Electron, Scanning; D010006:Osteoblasts / Q000166:cytology; D010982:Platelet-Derived Growth Factor / Q000008:administration & dosage; D011091:Polyesters; D020574:Proto-Oncogene Proteins c-sis; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D012038:Regeneration
D001672:Biocompatible Materials; D002130:Calcium Phosphates; D003692:Delayed-Action Preparations; D008567:Membranes, Artificial; D010982:Platelet-Derived Growth Factor; D011091:Polyesters; D020574:Proto-Oncogene Proteins c-sis; C485817:beta-tricalcium phosphate; D000077214:Becaplermin; C033616:poly(lactide); C018392:tricalcium phosphate